Vitamin D and Alopecia Areata: From Mechanism to Therapeutic Implications
Skin Appendage Disorders · 15.04.2025 · 1-17
DOI: 10.1159/000545711 ↗Kurz gefasst
Fachartikel in der Zeitschrift Skin Appendage Disorders, online erschienen am 15.04.2025. Verfasst von Erick Alejandro Jiménez-Herrera und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Centro Dermatológico "Dr. Ladislao de la Pascua", Mexico City, Mexico. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background: Alopecia areata (AA) is an autoimmune disorder and the second most common form of non-scarring hair loss, affecting approximately 1.7–2% of the global population. Although it predominantly presents before the age of 40, AA can occur at any age and is strongly associated with genetic predisposition. Environmental, hormonal, and psychological factors have been implicated in disease onset and progression. Recent evidence highlights the immunomodulatory role of vitamin D, traditionally recognized for its functions in bone metabolism and calcium homeostasis, in skin health and immune regulation, raising interest in its potential relevance to AA pathogenesis and treatment. Summary: This review examines the epidemiology, genetic predisposition, and immunological mechanisms underlying AA, emphasizing the loss of immune privilege in hair follicles as a key pathogenic event. Additionally, it examines the role of vitamin D and its receptor (VDR) in hair follicle homeostasis, discussing the association between vitamin D deficiency, altered VDR expression, and disease severity. Emerging clinical data suggest that vitamin D supplementation and analogs, such as calcipotriol, may serve as adjunctive therapeutic strategies, with potential benefits in mitigating disease severity and reducing relapse rates.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology Department, Centro Dermatológico "Dr. Ladislao de la Pascua", Mexico City, Mexico.
- Department of Internal Medicine, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.
- Department of Dermatology, Instituto Dermatológico de Jalisco "Dr José Barba Rubio", Zapopan, Mexico.
- Department of Nephrology, Bone and Mineral Metabolism, Centro Médico Nacional de Occidente, IMSS, Guadalajara, Mexico.
- Lipoprotein Metabolism Laboratory, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
- Trichology Clinic, Dermatology Department, Hospital General "Dr. Manuel Gea González", Mexico City, Mexico.
Zitieren
APA
Jiménez-Herrera, E. A., López-Zenteno, B. E., Corona-Rodarte, E., Parra-Guerra, R., Zubirán, R., Cano-Aguilar, L. E., Barrera-Ochoa, C., & Asz-Sigall, D. (2025). Vitamin D and Alopecia Areata: From Mechanism to Therapeutic Implications. Skin Appendage Disorders, 1-17. https://doi.org/10.1159/000545711
Vancouver
Jiménez-Herrera EA, López-Zenteno BE, Corona-Rodarte E, Parra-Guerra R, Zubirán R, Cano-Aguilar LE, et al. Vitamin D and Alopecia Areata: From Mechanism to Therapeutic Implications. Skin Appendage Disorders. 2025:1-17. doi:10.1159/000545711
BibTeX
@article{JimnezHerrera2025,
author = {Jiménez-Herrera, Erick Alejandro and López-Zenteno, Bianca Eunice and Corona-Rodarte, Eduardo and Parra-Guerra, Ricardo and Zubirán, Rafael and Cano-Aguilar, Luis Enrique and Barrera-Ochoa, Carlos and Asz-Sigall, Daniel},
title = {Vitamin D and Alopecia Areata: From Mechanism to Therapeutic Implications},
journal = {Skin Appendage Disorders},
year = {2025},
pages = {1--17},
doi = {10.1159/000545711}
}
EUVIMED